Condition

Obstructive Sleep Apnea (OSA) and Obesity

ClinicalTrials.gov condition label

Clinical trials2
Recruiting0
Common interventions2
Lead sponsors shown1

Clinical trials

2 shown
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) TherapyNCT07794397 · 2026-09-01
NOT_YET_RECRUITING
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) TherapyNCT07787260 · 2026-08-01
NOT_YET_RECRUITING

Trial status mix

NOT_YET_RECRUITING2

Phase mix

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.